YILDIRIM, R. Et Al. 2016. Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia. EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.13, no.2 , 111-115.

YILDIRIM, R., Sincan, G., PALA, C., Dudukcu, M., KAYNAR, L., Urlu, S. M., ... KİKİ, İ.(2016). Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia. EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.13, no.2, 111-115.

YILDIRIM, Rahşan Et Al. "Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia," EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.13, no.2, 111-115, 2016

YILDIRIM, Rahşan Et Al. "Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia." EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.13, no.2, pp.111-115, 2016

YILDIRIM, R. Et Al. (2016) . "Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia." EUROPEAN JOURNAL OF GENERAL MEDICINE , vol.13, no.2, pp.111-115.

@article{article, author={Rahşan YILDIRIM Et Al. }, title={Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia}, journal={EUROPEAN JOURNAL OF GENERAL MEDICINE}, year=2016, pages={111-115} }